Stahovica, Slovenia

Vlasta Humar

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2015-2018.

USPTO Granted Patents = 2 

% Patents Active = 50.0


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Vlasta Humar: Innovator in Pharmaceutical Technologies

Introduction

Vlasta Humar is a notable inventor based in Stahovica, Slovenia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of coated particles and dosage forms that enhance the stability of active substances.

Latest Patents

Vlasta Humar holds 2 patents related to her innovative work. Her latest patents focus on coated particles and pharmaceutical dosage forms that comprise active substances sensitive to environmental influences. The coating technology she developed provides stability and protection against oxidation and environmental humidity, ensuring the efficacy of the active substances.

Career Highlights

Throughout her career, Vlasta has been associated with Lek Pharmaceuticals D.d., a leading pharmaceutical company. Her work has been instrumental in advancing pharmaceutical formulations that are more resilient to environmental factors.

Collaborations

Vlasta has collaborated with several professionals in her field, including her coworkers Mateja Burjak and Rok Grahek. These collaborations have contributed to the successful development of her patented technologies.

Conclusion

Vlasta Humar's innovative work in pharmaceutical technologies showcases her dedication to improving the stability and effectiveness of medications. Her contributions are vital to the advancement of the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…